Company intelligence / Profile preview
Io Therapeutics, Inc.
Irvine, California, United Statesio-therapeutics.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Io Therapeutics is focused on discovering and developing small molecule therapeutics that target nuclear receptors for the treatment of cancer, neurodegenerative, and autoimmune diseases. The company has several compounds in its pipeline at various stages from discovery to early clinical development. No published results from advanced clinical trials were found.[1]
- Therapeutic areas
- OncologyImmunologyNeurology
- Modalities
- Small molecules (therapeutic compounds targeting nuclear receptors)
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Beyond the preview
Go deeper on Io Therapeutics, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Io Therapeutics, Inc..